key: cord-1012307-z19dt1b8
authors: Coe, Antoinette B.; Elliott, Marissa H.; Gatewood, Sharon B.S.; Goode, Jean-Venable R.; Moczygemba, Leticia R.
title: Perceptions and predictors of intention to receive the COVID-19 vaccine
date: 2021-05-01
journal: Res Social Adm Pharm
DOI: 10.1016/j.sapharm.2021.04.023
sha: ec501bf771b32596c13f698b5c54af3d09416a44
doc_id: 1012307
cord_uid: z19dt1b8

BACKGROUND: The control of the Coronavirus Disease 2019 (COVID-19) pandemic may be dependent on widespread receipt of an effective vaccine. It is important to understand patient health-related behaviors and perceptions to guide public health vaccination strategies. OBJECTIVES: To examine perceptions of COVID-19 and vaccination beliefs, and identify predictors of intention to receive the COVID-19 vaccine in the US. METHODS: A cross-sectional, web-based survey guided by the Health Belief Model was conducted using a web-based Qualtrics survey panel of US adults. The main outcome was the intention to receive the COVID-19 vaccine if offered. Additional measures included: demographics, perceptions of COVID-19 severity, risk and susceptibility, views of a potential COVID-19 vaccine, virus and vaccine information sources, vaccine beliefs and behaviors, and seasonal flu vaccine history. RESULTS: A total of 1,047 complete responses were included. Females had lower odds of intending to receive the COVID-19 vaccine than males (AOR = 0.54, 95% CI: 0.36 – 0.80). Those with a two-year degree/some college had lower odds of intending to receive the COVID-19 vaccine compared to those with a high school degree/GED (AOR = 0.59, 95% CI: 0.36 – 0.97). Respondents who perceived the severity of the virus to be higher, perceived a greater COVID-19 vaccine benefit, and perceived greater general vaccine benefits had higher odds of intending to receive a COVID-19 vaccine (AOR = 1.44, 95% CI: 1.09 – 1.91; AOR = 2.82, 95% CI: 2.24 – 3.56; AOR = 1.77, 95% CI 1.41 – 2.21, respectively). CONCLUSIONS: In this study, intention to receive the COVID-19 vaccine varied across demographics, perceived virus severity, COVID-19 vaccine and general vaccine beliefs. Successful implementation of a COVID-19 immunization strategy by healthcare providers and public health officials will need to incorporate diverse COVID-19 vaccination education strategies tailored to patients' health beliefs.

In March 2020, the World Health Organization (WHO) characterized Coronavirus 31

Disease 2019 (COVID-19) as a pandemic, which led to interruptions in daily life such as 32 closing businesses and schools and limiting social gatherings to prevent the spreading of 33 the virus. 1 COVID-19, caused by a novel coronavirus called severe acute respiratory 34 syndrome coronavirus 2 (SARS-CoV-2), primarily affects the respiratory system and in 35 some instances, can be fatal. 2, 3 As of August 17 th 2020 (when data collection began), 36 there were roughly 21.8 million cases and over 774 thousand deaths worldwide, with 37 about 5.4 million cases and 170,500 deaths in the United States (US). 4 With cases and 38 deaths continuing to rise, the long-term solution to mitigating the morbidity and mortality 39 related to COVID-19 will likely be dependent on a globally available COVID-19 40 vaccine. 5 However, for a safe and efficacious COVID-19 vaccine to be the solution, it 41 must also be widely accepted and received by the general public to guarantee broad 42 immunological protection. 5 

Vaccine hesitancy, which refers to individuals who may refuse, delay, or be 44 unsure of some vaccines, poses a major challenge to the success of vaccination 45 programs. 6 The WHO listed vaccine hesitancy as one of the ten threats to global health in 46 2019. 7 Previous studies on vaccine hesitancy have identified socioeconomic, 47 demographic, and other belief factors to play a large role in the likelihood of vaccine 48 acceptance. 6 49

The Health Belief Model (HBM), a health promotion framework that assesses and 50 predicts health-related behavior, has been used in studies to determine predictors of 51 vaccination. 8, 9 Previous work used the HBM to explore intention to receive the 2009 52 J o u r n a l P r e -p r o o f H1N1 vaccine and found that barriers to vaccination, physician recommendation, and 53 previous seasonal influenza vaccination were predictors of intent to receive the vaccine. 9 54

When considering the distribution and administration of the COVID-19 vaccine, public 55 health campaigns and strategies will need to address perceptions of vaccine-hesitant 56 individuals to increase vaccine uptake. Using the HBM to identify predictors of intention 57 to receive the COVID-19 vaccine will help inform vaccination campaigns. 58

Surveys regarding the intention to receive the COVID-19 vaccine in the US have 59 been published. [10] [11] [12] Two national surveys of COVID-19 vaccine acceptability among 60 national online survey panels were conducted in May 2020. 10, 12 One study found that the 61 majority of adults were willing to receive a COVID-19 vaccine, with the greatest 62 predictors being healthcare provider recommendation, higher levels of perceived 63 susceptibility, perceived severity, perceived effectiveness, and moderate or liberal 64 political leaning. 10 The other study found differences in vaccine acceptance by participant 65 demographics and geography. 12 In July 2020, a third online survey of US adults assessed 66 factors related to the likelihood of accepting a COVID-19 vaccine. 11 There are six constructs in the HBM: perceived susceptibility, perceived severity, 84 perceived benefits, perceived barriers, cues to action, and self-efficacy. 8 Perceived 85

susceptibility is the individual's belief surrounding their risk of getting a condition or 86 disease whereas perceived severity is the belief about how serious the condition or 87 disease will be. Perceived benefits and perceived barriers are related to the beliefs around 88 the efficacy and the costs of the advised action, respectively. Cues to action are strategies 89 to encourage a state of "readiness," while self-efficacy is the belief in one's ability to do 90 something. 8 All HBM constructs were used in this study and are reflected in the survey 91 question items. 92

A 60-item questionnaire was developed to collect information on demographics, individual that might be at an increased risk for severe illness (i.e., potentially high-risk 99 group). These high-risk groups were defined by the Centers for Disease Control and 100

Prevention (CDC) as groups at increased risk or might be at an increased risk for severe 101 illness from COVID-19. 3 A list of these high-risk groups was provided in the 102 questionnaire for the respondent to check all that apply. This survey was adapted from a 103 previous survey that assessed predictors of intent to receive the novel (2009) H1N1 104 influenza vaccine. 9 The survey instrument is included as online material. 105

The first series of questions on demographics asked respondents for their age, 106 gender, race, ethnicity, US region, education level, annual household income, if they are 107 a member or living with a member of a COVID-19 high-risk group, and if they are a 108 member or living with someone who might be at high-risk for serious illness from 109 COVID-19, according to CDC definitions at the time of survey administration. 3 The The survey was pre-tested two times among faculty and graduate students for 120 clarity and accuracy. The survey was modified based on feedback, which included minor 121 revisions to the response options, the format, and the question wording. The survey did 122 not collect any identifiable patient information. The Institutional Review Board at the 123 blinded for review approved this study. 124

The Qualtrics survey was distributed to a nationally representative online survey 126 panel in the US. Responses were collected until there was a minimum of 1,000 completed 127 surveys that met the four pre-specified demographic quotas. Qualtrics compensated each 128 respondent for their participation. All responses were collected anonymously. Survey 129 responses were collected from August 17-20, 2020. 130

Data were analyzed using descriptive statistics and presented as number 132

(percentage), median (interquartile range), or mean (standard deviation). The main 133 outcome was the intention to receive a COVID-19 vaccine, analyzed as Yes (very likely 134 and likely to receive the vaccine) vs. No (very unlikely and unlikely to receive the 135 vaccine). Multivariable logistic regression was used to examine the association between 136 demographic, seasonal influenza vaccine history, and HBM variables with the intention 137 to receive a COVID-19 vaccine. Results are presented as odds ratios (OR) and adjusted 138 odds ratios (AOR) with 95% confidence intervals. To assess reliability for the HBM 139 variables, Cronbach's alpha was calculated for the domains with three or more items and 140

Pearson's correlation was used for the domain with two items. Scale means were 141 calculated for domains with a Cronbach's alpha or Pearson's correlation value > 0.5. A 142 post-hoc analysis using the χ 2 test was conducted to identify differences in perceived 143 comfort of receiving a COVID-19 vaccine at different locations (doctor's office, 144 pharmacy, or drive-through car site) between respondents that were likely or unlikely to 145 receive a COVID-19 vaccine. The a priori level of significance was p <0.05. Analyses 146 were performed using SAS software (version 9.4, Cary, NC). 147

Demographics 149

A total of 1,050 respondents completed the survey. Of the 1,050 total respondents, 150 three were excluded because of incomplete responses. The majority were under the age of 151 65 years old (883, 84.3%), non-Hispanic or Latino (865, 82.6%), and white (755, 72.1%) 152 (Table 1 ). There were slightly more female respondents (584, 55.8%). A little over one-153 third of the respondents were located in the South (392, 37.4%). Over one-third of the 154 respondents had an annual household income of $15,000 to $49,000 (387, 37.0%). 155

Most respondents had a history of receiving a seasonal influenza vaccine (732, 157 69.9%) ( Table 1) . Approximately half had received the seasonal influenza vaccine last 158

year (554, 52.9%). Of those who received the seasonal influenza vaccine last year, most 159 received it at their physician's office (223/554, 40.3%). 160

Approximately half of the respondents identified as a member of a COVID-19 162 high-risk group (535, 51.1%) or a member of a potentially high-risk group (609, 58.2%) 163 as classified by the CDC (Table 2 ). 3 Table 1 . 174

When respondents were asked if they were willing to get all recommended 176 vaccines for themselves, the majority agreed with the statement (631, 60.3%) ( Table 3) . 177

If offered a COVID-19 vaccine, most of the respondents indicated that they were likely 178 or very likely to receive it (663, 63.3%). If the COVID-19 vaccine were to be 179 administered in more than one dose, roughly the same number of respondents reported 180 being likely or very likely to receive it (639, 61.0%). If the COVID-19 vaccine was 181 required to return to work or school, most respondents selected likely or very likely to 182 receive a COVID-19 vaccine (634, 60.6%). 183

The majority of respondents likely to receive a COVID-19 vaccine reported they 184 were comfortable getting a COVID-19 vaccine at a doctor's office, pharmacy, or drive-185 through car site (75.4%, 67.3%, and 60.9%, respectively). In those unlikely to receive a 186 COVID-19 vaccine, approximately half reported that they were uncomfortable getting a 187 J o u r n a l P r e -p r o o f COVID-19 vaccine at a doctor's office, pharmacy, or drive-through care site (49.5%, 188 53.4%, and 58.6%, respectively)(Supplemental Table 2 ). 189

Older adults had higher odds of intending to receive the COVID-19 vaccine than 191 those under age 65 (OR = 1.71, 95% CI: 1.18 -2.47) ( Table 4) 

Respondents with a higher perceived COVID-19 vaccine benefit had higher odds 229 of intending to receive the COVID-19 vaccine in both unadjusted and adjusted logistic 230 regression models (OR = 4.35, 95% CI: 3.58 -5.28 and AOR = 2.82, 95% CI: 2.24 -231 3.56). Those who perceived greater overall general vaccine benefits also had higher odds 232 of intending to receive a COVID-19 vaccine (OR = 3.10, 95% CI: 2.64 -3.64 and AOR 233 = 1.77, 95% CI 1.41 -2.21). 234

Respondents' perceived clinical and access barriers to COVID-19 vaccination 236

were not significant predictors of intention to receive the COVID-19 vaccine. Summary 237 responses to the HBM domains are provided in Supplemental Table 3 . Figure 1 provides 238 the conceptual model for this study with significant HBM domains. 239

This study found that roughly 6 in 10 adults in the US intend to receive a COVID-241 19 vaccine if offered. This finding is slightly lower than other surveys conducted in the 242 US, which found 67 -69% of adults reported a willingness to get a COVID-19 243 vaccine, 10,12,13 but higher than other parts of the world. 14, 15 Though most respondents in 244 this US study intended to receive the COVID-19 vaccine, it is still a significant public 245 health concern that 40% did not intend to get the vaccine. 246

For the HBM domains in this study, perceived severity of the virus, perceived 247 greater COVID-19 vaccine benefit, and perceived overall general vaccine benefits were 248 all predictors of the respondent's intention to receive a COVID-19 vaccine. These 249 findings are consistent with previous studies on vaccination that support the notion that 250 detecting the behaviors, beliefs, and perceptions of respondents will likely increase 251 vaccine uptake and decrease health disparities in vaccine receipt. 6, [9] [10] [11] [12] 16 Other HBM 252 domains in this study, perceived COVID-19 virus susceptibility, clinical barriers, and 253 access barriers to the COVID-19 vaccine were not significant predictors of the 254 respondent's intention to receive the COVID-19 vaccine in the multivariable model. In 255 contrast, one study indicated that perceived severity was not a significant predictor of 256 intention to receive the COVID-19 vaccine. 17 The study by Guidry et al. found that 257 perceived susceptibility, benefits, barriers, and self-efficacy were predictors of vaccine 258 uptake intent. 17 The variance of significant HBM predictors across studies indicates a 259 need to determine each individual's concerns and provide concordant vaccine education. 260

This study supports that strategies to increase COVID-19 vaccine uptake should 261 address the HBM domains of perceived virus severity and belief in vaccine benefits. 262

Evidence-based strategies may include using effective communication (e.g., motivational 263 interviewing) to educate patients and reinforcing the role of community protection 264 (vaccine benefits) to increase vaccine receipt. 18 A recent study indicated that perceived 265 community benefit was associated with respondents' intention to receive a COVID-19 266 vaccine. 19 267

Although not a significant finding in this group of survey respondents, addressing 268 concerns about immunization side effects or barriers is recommended as a strategy to 269 increase vaccine uptake. Studies have indicated that safety concerns or barriers were 270 associated with a negative intention to receive a COVID-19 vaccine and addressing these 271 patient-specific concerns may increase vaccine receipt. 17,19 272 Our findings suggest that those who were likely to intend to receive a COVID-19 273 vaccine were comfortable receiving the vaccination at a doctor's office, a pharmacy, or a 274 drive-through car site, based on the survey options provided. For those who are likely to 275 receive a COVID-19 vaccine, improved convenience and access to vaccines are strategies 276 to increase vaccine uptake. 20 With these findings, public health officials should increase 277 the number of accessible community-based vaccination sites, such as doctor's offices, 278 pharmacies, large vaccination events, local churches, and schools. 279

In this study, females were less likely to intend to receive a COVID-19 vaccine 280 which is consistent with previous survey research on acceptance of the COVID-19 281 vaccine. 10, 11 In only the unadjusted model, self-reported Black or Other race respondents 282

were less likely to intend to receive the COVID-19 vaccine than White respondents. 283

Another survey indicated that Black race respondents compared to White race 284 respondents were less likely to intend to get the COVID-19 vaccine, including under 285 emergency use authorization. 17 This study found that respondents with an annual 286 household income of less than $15,000 were less likely to intend to receive the COVID-287

19 vaccine in an unadjusted model, similar to another study. 13 Variation in intent to 288 receive the COVID-19 vaccine was seen by region of the US, as seen in work by Malik et 289 al. 12 This study demonstrates that intention to receive the COVID-19 vaccine differs 290 across demographic characteristics, such as education level, area of the US, and gender. 291

This highlights the need for vaccination strategies that specifically address certain 292 demographic groups. 293

While this study's demographics were matched to the US adult population, 295 participation was limited to those who participate in Qualtrics survey panels, which may 296 not reflect the overall population. A second limitation is that trust was not included as a 297 survey component and cannot be assessed as a predictor of vaccine receipt. Another 298 limitation is the changing context of COVID-19 vaccine information and news reporting. 299

This study was conducted in mid-August 2020 before emergency use authorization of 300 COVID-19 vaccines. Another limitation is that this study did not examine the actual 301 health behavior of receiving a COVID-19 vaccine. However, this study provides useful 302 information on vaccine perceptions before a vaccine is available to the public that may 303 help design future pandemic responses. Each day during the pandemic brings new 304 information to the public, which may affect respondent perceptions. 305

The level of vaccine uptake will likely be a major factor in resolving the COVID-307 19 pandemic. These findings demonstrate that intention to receive the COVID-19 vaccine 308 varied across demographics, perceived virus severity, and vaccine beliefs. Thus, 309 successful implementation of a COVID-19 immunization campaign by healthcare 310 providers and public health officials will need to incorporate diverse COVID-19 311 vaccination education strategies tailored to patients' health beliefs that encourage vaccine 312 acceptance and receipt. 313 J o u r n a l P r e -p r o o f 

World Health Organization. Listing of WHO's response to COVID-19

COVID-19 pathophysiology: A review

COVID-19) -About COVID-19

Planning for a COVID-19 vaccination program

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature

World Health Organization. Ten Threats to Global Health

The Health Belief Model

The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine

Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine

Factors associated with US adults' likelihood of accepting COVID-19 vaccination

Determinants of COVID-19 vaccine acceptance in the US

Will they, or Won't they? Examining patients' vaccine intention for flu and COVID-19 using the Health Belief Model

Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong

Determinants of COVID-19 vaccine acceptance in a high infection-rate country: a cross-sectional study in Russia. Pharmacy Practice

A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy

Willingness to get the COVID-19 vaccine with and without emergency use authorization

Addressing barriers to vaccine acceptance: an overview

Integrating health behavior theories to predict American's intention to receive a COVID-19 vaccine

The 5As: A practical taxonomy for the determinants of vaccine uptake